BIAFINE

This brand name is authorized in Ecuador, France, Israel, Malta, Tunisia.

Active ingredients

The drug BIAFINE contains one active pharmaceutical ingredient (API):

1
UNII 9O3K93S3TK - TROLAMINE
 
Read more about Trolamine

Medication package inserts

Below package inserts are available for further reading:

Document Type Information Source  
 BIAFINE Emulsion for cutaneous application MPI, EU: SmPC Medicines Authority (MT)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group Classification
D03AX12 D Dermatologicals → D03 Preparations for treatment of wounds and ulcers → D03A Cicatrizants → D03AX Other cicatrizants
Discover more medicines within D03AX12

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
EC Agencia Nacional de Regulación, Control y Vigilancia Sanitaria 582-MEE-0115
FR Base de données publique des médicaments 69931588
IL מִשְׂרַד הַבְּרִיאוּת 3003, 3004
MT Medicines Authority MA065/00101
TN Direction de la Pharmacie et du Médicament 11283011, 11283012

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈